SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-371146
Filing Date
2013-09-19
Accepted
2013-09-19 09:01:33
Documents
10
Period of Report
2013-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d600679d8k.htm 8-K 28114
2 EX-1.1 d600679dex11.htm EX-1.1 52262
3 EX-4.1 d600679dex41.htm EX-4.1 70329
4 EX-5.1 d600679dex51.htm EX-5.1 7244
5 EX-10.1 d600679dex101.htm EX-10.1 147735
6 EX-99.1 d600679dex991.htm EX-99.1 7527
7 EX-99.2 d600679dex992.htm EX-99.2 7423
8 GRAPHIC g600679ex1_1p1.jpg GRAPHIC 19185
9 GRAPHIC g600679ex991logo.jpg GRAPHIC 6944
10 GRAPHIC g600679img1.jpg GRAPHIC 5735
  Complete submission text file 0001193125-13-371146.txt   366268
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 131104780
SIC: 2836 Biological Products, (No Diagnostic Substances)